Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma

dc.contributor.author	Weisel, Katja
dc.date.accessioned	2020-08-26T08:08:33Z
dc.date.available	2020-08-26T08:08:33Z
dc.date.issued	2019
dc.identifier.issn	1532-1827
dc.identifier.uri	http://hdl.handle.net/10900/105728
dc.language.iso	en	en
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41416-019-0581-8
dc.subject.ddc	610	de_DE
dc.title	Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00813
utue.publikation.seiten	751-757	de_DE
utue.personen.roh	Ludwig, Heinz
utue.personen.roh	Poenisch, Wolfram
utue.personen.roh	Knop, Stefan
utue.personen.roh	Egle, Alexander
utue.personen.roh	Schreder, Martin
utue.personen.roh	Lechner, Daniel
utue.personen.roh	Hajek, Roman
utue.personen.roh	Gunsilius, Eberhard
utue.personen.roh	Krenosz, Karl Jochen
utue.personen.roh	Petzer, Andreas
utue.personen.roh	Weisel, Katja
utue.personen.roh	Niederwieser, Dietger
utue.personen.roh	Einsele, Hermann
utue.personen.roh	Willenbacher, Wolfgang
utue.personen.roh	Melchardt, Thomas
utue.personen.roh	Greil, Richard
utue.personen.roh	Zojer, Niklas
dcterms.isPartOf.ZSTitelID	British Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	9	de_DE
dcterms.isPartOf.ZS-Volume	121	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)